CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
short fiber reinforced composite , long fiber reinforced composite, light cure glass, flowable compositeother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07285772
NCT07285772N/ACompleted
CompareCT.gov

Clinical Performance of Various Bilayer Biomimetic Resin Composite Strategies

Tanta University·interventional·Posted Dec 16, 2025·Updated Dec 16, 2025

In Brief

A clinical study evaluating short fiber reinforced composite , long fiber reinforced composite, light cure glass, flowable composite for Composite Restoration and Composites Resins. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The purpose of this study was to evaluate several bilayer biomimetic composite resin techniques in class I cavities over the course of 18 months in a randomized, double-blind clinical trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsComposite Restoration, Composites Resins
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedDec 16, 2025
Enrollment StartJan 1, 2024
Primary CompletionOct 10, 2025
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 7 months ago

Interventions

short fiber reinforced composite , long fiber reinforced composite, light cure glass, flowable compositeother

All patients received four various bilayer biomimetic restorations in four groups (n = 40) as follows: Group I: short fiber reinforced composite (everX Posterior); ); Group II: long fiber reinforced composite (Ribbond Inc., USA); Group III: glass ionomer restorative materials (Riva SDI); and Group IV: flowable composite (G-aenial universal).